Effect of Guanidine Derivatives of Quinazoline on Na + /H + -Exchanger and Intraocular Pressure

A. S. Taran; Таран А. С.; L. V. Naumenko; Науменко Л. В.; Ju. A. Govorova; Говорова Ю. А.; N. A. Gurova; Гурова Н. А.; A. A. Spasov; Спасов А. А.; A. A. Ozerov; Озеров А. А.; D. V. Merezhkina; Мережкина Д. В.

doi:10.31857/S0132342323020215

Effect of Guanidine Derivatives of Quinazoline on Na⁺/H⁺-Exchanger and Intraocular Pressure

Authors: Taran A.S.¹^,2, Naumenko L.V.¹, Govorova J.A.¹, Gurova N.A.¹, Spasov A.A.¹^,2, Ozerov A.A.¹^,2, Merezhkina D.V.¹
Affiliations:
1. Volgograd State Medical University, Ministry of Healthcare of the Russian Federation
2. Volgograd Medical Scientific Center
Issue: Vol 49, No 2 (2023)
Pages: 207-215
Section: Articles
URL: https://rjmseer.com/0132-3423/article/view/670673
DOI: https://doi.org/10.31857/S0132342323020215
EDN: https://elibrary.ru/PGNDUV
ID: 670673

Cite item

Full Text

Open Access
Restricted Access

Access granted
Restricted Access

Subscription Access

Abstract

Based on the data of the role of Na⁺/H⁺-exchanger (NHE) in the modulation of intraocular pressure, which is the main factor in the development of glaucoma, and previously conducted studies by various authors proving the presence of inhibitory NHE-1 activity in quinazoline derivatives, nine new compounds belonging to this class were synthesized. The effect of the obtained quinazoline derivatives on the inhibition of Na⁺/H⁺-exchanger and their on intraocular pressure (IOP) in comparison with zoniporide (NHE inhibitor) and timolol (a drug for lowering IOP used in clinical practice) was studied. Among the compounds studied in vitro, all quinazoline derivatives at a concentration of 1 nM inhibited the activity of NHE-1, the most active compound was a derivative of quinazoline acetylguanidine. However, not all compounds showed IOP-reducing activity in vivo in rats. So the most active of the quinazoline derivatives are 4-oxoquinazoline acetylguanidine, its brominated derivative at position C6 and quinazoline propionylguanidine. The structure–activity analysis showed that the presence of the Br atom at the C6 position of the 4-oxoquinazoline acetylguanidine derivative leads to a maximum decrease in IOP during instillation of the solution of the compound.

Keywords

Na⁺/H⁺-exchanger (NHE), intraocular pressure (IOP), glaucoma, quinazoline, melatonin bioisosters

References

Балалин С.В., Фокин В.П. // Клиническая офтальмология. 2019. Т. 19. С. 43–48. https://doi.org/10.21689/2311-7729-2019-19-1-43-48
Avila M.Y., Seidler R.W., Stone R.A., Civan M.M. // Invest. Ophthalmol. Vis. Sci. 2002. V. 43. P. 1897–1902.
Mandal A., Shahidullah M., Delamere N.A., Terán M.A. // Am. J. Physiol. Cell Physiol. 2009. V. 297. P. C111–C120. https://doi.org/10.1152/ajpcell.00539.2008
Lupachyk S., Stavniichuk R., Komissarenko J., Drel V., Obrosov A., El-Remessy B., Pacher P., Obrosova I. // Int. J. Mol. Med. 2012. V. 29. P. 989–998. https://doi.org/10.3892/ijmm.2012.933
Fidzinski P., Salvador-Silva M., Choritz L., Geibel J., Coca-Prados M. // Am. J. Physiol. Cell Physiol. 2004. V. 287. P. C655–C663. https://doi.org/10.1152/ajpcell.00552.2003
Spasov A., Ozerov A., Vassiliev P., Kosolapov V., Gurova N., Kucheryavenko A., Naumenko L., Babkov D., Sirotenko V., Taran A., Litvinov R., Borisov A., Klochkov V., Merezhkina D., Miroshnikov M., Uskov G., Ovsyankina N. // Sci. Rep. 2021. V. 11. P. 1–13. https://doi.org/10.1038/s41598-021-03722-w
Спасов А.А., Гурова Н.А., Тимофеева А.С., Сорокин С.М. // Эксперим. и клинич. фармакология. 2014. Т. 77. № 6. С. 13–17.
Pedersen S.F., Counillon L. // Physiol. Rev. 2019. V. 99. P. 2015–2113. https://doi.org/10.1152/physrev.00028.2018
Gubin D., Neroev V., Malishevskaya T., Cornelissen G., Astakhov S., Kolomeichuk S., Yuzhakova N., Kabitskaya Y., Weinert D. // J. Pineal Res. 2021. V. 70. P. e12730. https://doi.org/10.1111/jpi.12730
Озеров А.А., Новиков М.С., Глухова Е.Г. // Усп. соврем. естествознания. 2016. № 2. С. 53–56.
Гурова Н.А., Спасов А.А., Питерсен А.С. // Вестник Волгоград. гос. мед. ун-та. 2011. № 2. С. 70–72.
Спасов А.А., Гурова Н.А., Харитонова М.В. // Эксперим. и клинич. фармакология. 2013. Т. 76. № 1. С. 43–48.
Rosskopf D., Morgenstern E., Scholz W., Osswald U., Siffert W. // J. Hypertens. 1991. V. 9. № 3. P. 231–238.
Kusumoto K., Igata H., Abe A., Ikeda S., Tsuboi A., Imamiya E., Fukumoto S., Shiraishi M., Watanabe T. // Br. J. Pharmacol. 2002. V. 135. P. 1995–2003. https://doi.org/10.1038/sj.bjp.0704647
Солодунова Е.А., Новиков М.С., Озеров А.А. // Волгоград. научно-мед. журн. 2015. № 3. С. 36–38.
Солодунова Г.Н., Волкова А.О., Коршенинникова А.С., Кучеренко А.Р., Скороход Е.Д., Толкачева В.И., Турченкова К.В., Турченкова Л.В. // Волгоград. научно-мед. журн. 2018. № 2. С. 20–22.
Marcus A.J., Iezhitsa I., Agarwal R., Vassiliev P., Spasov A., Zhukovskaya O., Anisimova V., Ismail N.M. // Data Brief. 2018. V. 18. P. 523–554. https://doi.org/10.1016/j.dib.2018.03.019